Some Johnson & Johnson Covid Vaccine Doses Delayed in USA by Factory Mix-Up
However Anand added that final details are still being worked out and she can not say just how many doses will arrive in Canada in the first delivery. In a statement, J&J said it's working with federal authorities to deliver 24 million doses of the vaccine in April.
It does not affect Johnson & Johnson doses that are now being delivered and used nationwide.
Representatives for Emergent BioSolutions declined to comment, deferring to Johnson & Johnson's statement.
J&J had pledged to provide 20 million doses of its vaccine to the US government by the end of March, and 80 million more doses by the end of May.
U.S. officials said the vaccine spoilage will not impact plans to provide enough vaccine to immunize every adult by May.
Future Johnson & Johnson vaccine shipments delayed in US after 15 million doses ruined: report
Johnson & Johnson said on Friday (29 January) that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will give health officials another weapon to tackle the coronavirus.
This latest vaccine news comes at a time of increased concerns around the AstraZeneca shot after the NACI advised provinces to suspended the use of the vaccine for anyone under the age of 55 as a precautionary measure, pending further investigation. The paper reported that federal officials said the mistake was caused by human error.
As of Wednesday, J&J had provided about 6.8 million doses, according to the U.S. Centers for Disease Control and Prevention's online vaccine tracker.
As of this posting, the CDC is reporting a total of 150 million vaccine doses administered - which includes over 50 million Americans fully vaccinated and over half of all seniors fully vaccinated.
Emergent spotted the issue and notified the FDA, J&J said.